BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial

10x Genomics BlogWhy 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance

10x Genomics Blog10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News

10x Genomics News10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News

Science Daily BiotechA rare cancer-fighting plant compound has been decoded

Eli LillyEli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - Stocktwits

Endpoints NewsLilly points to low-dose Zepbound and Foundayo as weight loss maintenance options

IlluminaThe Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st

Siemens HealthineersA Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.st

LabCorpLabcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab Products

FierceBiotechFDA Commissioner Marty Makary to resign, capping turbulent tenure: report

FierceBiotechKyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis

Eli LillyEli Lilly Price Prediction: This Is Where The Stock Will End This Year - 24/7 Wall St.